chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt stated 2-3 days after receiving influenza vaccination, in (L) deltoid, muscle in neck felt tight, painful, (Left side) pt stated needed physical therapy has concurrent fibromyalgia.
Narrative:  RLE extensive DVT - no lymphoma progression on CT scan, prior disease site shows further improvement. Pt received 2 nd COVID vaccine on 2/10 -> diarrhea started right after the vaccine. ?DVT related to vaccine toxicity? Will ask Pt to report his symptoms. - Start Lovenox 80 mg BID Patient reports diarrhea since starting his covid vaccinations.
02/25/22 I was unable to speak the last word of a sentence. I felt funny, felt different.  I tried to sit down and relax through it.  This lasted for about 3-4 hours for it to completely go away. I called my doctor and was unable to see him until March 1, 2022.  He saw no adverse effects and assumed it was a TIA.  Within the week, I had an echocardiogram and a CT of my head.  I went back to the doctor the next week and my doctor, there were no problems with the echocardiogram or CT. He had me wear a heart monitor for one week.  This showed I had A Fibrillation. Then my doctor told me he wanted me to have a stress test. I was hooked up and before the test started, it showed AFib . My doctor got me in to see a Cardiologist in July.  I was already on Zarelto and Metoprolol from the previous doctor?s visit. The Cardiologist added Multaq.  At the end of November of 2022, I went back to see the Cardiologist and he felt my heart was controlled but put me back on a heart monitor for 2 weeks starting on December 2, 2022.  I had a TIA on December 8,2022. I went to the Emergency Department and I had a CT of the head.  The Heart Monitor company called yesterday to say they had received the heart monitor, but there are no results yet.
Reported being light headed before walking in for the vaccine per behavior specialist.  164/114 right lying  154/104 right sitting       1330 PSO2 98 pulse78      1410  Pso299  pulse 62  Informed to seek medical attention for further problems
Full body aches, fever of 101.1, chills, headache, fatigue, night sweat. These all started about 10 pm the day of the vaccine and was better Monday 4/5/21
4/7/2021--Patients boyfriend called to report that patient has had adverse reaction to her 2nd dose of Moderna vaccine given on 4/1/21. He reports that after the vaccine was given she bled a lot and is concerned if this has contributed to her adverse reaction. She has had headache, cloudy vision, dizziness, brain fog, muscle fatigue, body aches and chills. She is still experiencing most of these side effects even though it's been about 6 days since her shot. Some of this are listed as common side effects to the vaccine but the cloudy vision, dizziness and brain fog were concerning to me - I recommended that she follow up with provider, especially if side effects have not improved by end of the day. It sounds like she's already been to the urgent care about this but did not receive much help there.
This Report describes swelling in a 19 y.o. male who received Havrix vax. The PT had no allergies and did not know if he had had any other reactions to previous vax's. Concurrent medications were not specified. On 3/8/02, the vaccinee received his first injection of Havrix. That evening at about 21:00, both hands and eyelids began to swell. The swelling went away by the next morning, but returned to a lesser extent the next evening. No medical attention was required. The reporting nurse states that "they really don't think it is necessarily related to the Havrix; could be anything." As of 3/20/02, the swelling resolved.
Minutes after vaccine was given, tingling felt down left arm, then after 15 min. felt tingling down both legs and feet. 30 minutes after vaccine, tingling in limbs, hand numbness and brain fog. ED response was called.  Monitored in ED, EKG, blood glucose, blood pressuue monitored, urine test. Oral dose Benadryl given.  Discharged home in 2 hours.
Redness to L arm post inj. 3 days - > 2", tender to touch. pt was out of town - went to urgent care - Rx - Antibiotics Bactrim
Had shots on 2-6-06. Had 2 shots in rt thigh and 1 in left thigh. Pt's legs are swollen and red, no fever and feeding well moving extremities normally.
Information has been received from a registered nurse concerning a 20 years old female patient with penicillin allergy and no pertinent medical history who on 27-APR-2009 was vaccinated with a dose of MMR II (lot # 660209/1119X).  Concomitant therapy included tuberculin purified protein derivative (manufacturer unknown) given at the same visit.  Subsequently, about 1 week after vaccination, the patient experienced fever of 102 F, flu like symptoms and parotitis.  The patient was seen for an office visit, TYLENOL was prescribed for fever.  At the time of reporting, the patient had not recovered.  Follow-up information has been received from a registered nurse concerning the female patient with penicillin and latex allergy.  It was reported that on 27-APR-2009 at 9:00 AM, the patient received SQ in her right arm the second dose of MMR II.  Per patient on 04-MAY-2009, she developed fever and parotitis.  The final patient's outcome was unknown as the patient never returned to the office.  No further information is available.
Tenderness at injection site; Pain at injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain at injection site) and INJECTION SITE PAIN (Tenderness at injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (Pain at injection site) and INJECTION SITE PAIN (Tenderness at injection site). At the time of the report, INJECTION SITE PAIN (Pain at injection site) and INJECTION SITE PAIN (Tenderness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication  was provided. No concomitant medication were provided.
Information has been received from a medical assistant referring to multiple unspecified patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored PROQUAD (lot # reported as M027347, expiration date 01-JUN-2018; lot # reported as M000998, expiration date 07-JAN-2018, dose and route not reported). The doses of vaccine were exposed to 3 defrost cycles, each cycle was reaching 6 degree Fahrenheit for 5 minutes. Data logger was involved. There were no prior excursions. No adverse effects were reported. Additional information has been requested.
lump in my arm; I would hurt this bad; feel like I want to die from the pain; This case was reported by a consumer via call center representative and described the occurrence of mass in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced mass, pain in arm and feeling unwell. On an unknown date, the outcome of the mass, pain in arm and feeling unwell were not recovered/not resolved.   It was unknown if the reporter considered the mass, pain in arm and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per the vaccine indication. The patient never had chicken pocks. The patient received Shingrix and get a lump in his/her arm and hurt this bad from taking the shot.  The patient felt like want to die from the pain.
Patient states ate lunch at 1PM, then at about 3 or 3:30 had chills, fever, headache and vomited twice.  No further complaint.  No local reaction at injection site noted, only some soreness.
vesicular, macular, papular rash 2 wks p/vax; numbness & tingling, aching pain in both wrists 16-17 p/vax; slurred speech 2-3 days p/vax;
Swelling in lips and cheeks at site of filler injections done on 11/18/2020
pt recv vax 4NOV97 1045AM & pt c/o diff swallowing, feels like throating closing @ 11AM:BP 122/90 denied any allergies, given DPH;auscultated all obese;pt advised to be seen in ER;inc fluids;
Fever of 100.5 F by mouth and malaise. Oral lesions, and hand lesions then notiecable on 11/06/2010.  Diagnosed with hand, foot mouth disease.
Gave an expired lot to 85 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Gave an expired lot to 85 patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Gave an expired lot to 85 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Gave an expired lot to 85 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter mentioned that his facility had a vaccination clinic on 10-Nov-2021 and 15-Nov-2021, where a total of 85 doses were administered to patients from an expired lot of the Moderna COVID-19 vaccine. Lot # 046C21A expired on 6-Nov-2021 per Moderna's online lookup tool. On 10-Nov-2021, 4 doses were administered as 1st and 2nd doses and 73 doses were administered as booster doses. On 15-Nov-2021, 6 doses were administered as 1st and 2nd doses and 2 doses were administered as booster doses. Per the reporter, no adverse reactions have been reported by any patients so far. Caller did not have any patient identifiers at this time. It was also reported that the vial did not underwent any temperature excursions.  No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Follow up received contains no new information.
The patient experienced a fever of 103F and irritability 24 hours post vax. The symptoms were resolved within 72 hours.
patient received the second dose of the shingrix vaccine 30 days after the first dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: patient received the second dose of the shingrix vaccine 30 days after the first dose.). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 18-Oct-2023 The case was received from the pharmacist. The patient received second dose of the shingrix vaccine 30 days after the first dose, which led to shortening of vaccine schedule. The follow-up could not be possible as no contact details were available.
PATIENT APPEARED VERY PALE, FELT NAUSEOUS, DIZZY, AND SWEATING.  NO BREATHING PROBLEM, NO SWELLING OF LIPS OR THROAT.    ACCOMPANYING FRIEND SAID PATIENT DID NOT HAVE ANY BREAKFAST BEFORE VACCINATION.   PHARMACY STAFF HELP ALLEVIATE PATIENT'S LEGS AND ENSURED ADEQUATE VENTILATION.
Client received 2nd Dose of Pfizer vaccine and started H/A, described it as the worst H/A she had ever had. Took Acetaminophen and getting some relief. Did not experience H/A with the first dose of vaccine.
pt recvd vax seen by MD for swollen & erythematous lt thenar & fever of 39C; adm to hosp same day; cellulitis in lt thenar devel abscess which required surgical drainage; fluid & blood culture pos for H. influenzae type B;
Itchiness at injection site, persistent but not constant. Some warmth and subtle redness, but no rash.
LARGE RED LUMP WITH BLISTER L POSTERIOR UPPER ARM QUARTER SIZE DIAMETER. PAINFUL TO TOUCH. 3 SMALL BLISTERS AT L ELBOW. DEVELOPED 4/15/09. PT HAD STUFFY RUNNY NOSE WITH SLIGHT COUGH FOR 4 DAYS PRIOR TO DATE OF VACCINATION 4/2/09. TEMP 98.6 LUNGS CLEAR HEENT WNL..GETTING BETTER.4/7/09 PT DEVELOPED 103 FEVER WENT TO PMD DR 4/10 DX OTITIS PLACED ON AMOXICILLIN. 4/16/09 PT STILL HAS BLISTER TYPE RASH.
This case was reported by a nurse via sales rep and described the occurrence of pain in arm in a patient who received BEXSERO (batch number 151301D, expiry date 31st December 2016). On an unknown date, the patient received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced severe arm pain after vaccination. The representative did not have any patient identifiers.
I was asked by another nurse where the lot # was for Hepatitis A vaccine because she could not find it in the template format we use at the clinic. The vaccine was taped to a sticky note, asking that information. The vaccine that was taped to the sticky note was an adult dose Hepatitis A (1.0ml). The patient she was administering it to was under 18 years of age; therefore, needing a 0.5ml dose. I was asked to report the error as I am the immunization coordinator for the clinic. The nurse did speak with our supervisor about what to do next, and she was instructed to call our VFC coordinator at the state level. I am unsure if parents were ever called and informed of the vaccine administration error.
48 hours after administration patient experienced fever - temp max 104 degrees, admitted to hospital x 5 days with diagnosis of pneumonia and A fib.
Information has been received from a health professional concerning a white 5 yr old healthy female with no allergies or medical history who on 15Jul05, at approx 9:00AM, was vaccinated in the left arm with a second dose of varicella virus vaccine live (lot 651042/0214R). There was no illness at the time of vaccination. On 16Jul05 the pt developed pink bumps on her face. Now, on approx 19Jul05 the pt had fluid filled blisters that are itchy. No treatment was prescribed at this time. Unspecified medical attention was sought. The pt is not recovered. No product quality complaint was involved. Follow up information has been received from the physician which indicated that 4 days after the vaccine, on 19Jul05, the pt developed an itchy, blistered rash. About 15 lesions in total on the face and trunk. It was noted that the pt's mother was told it was chickenpox. The pt did not come to the office for any further evaluation. No laboratory tests were performed and the pt recovered on an unk date. It was reported that the first dose of varicella virus vaccine live was received on 30Nov00. Additional information is not expected.
Fever, Chills, Body ache, chest pain, next morning had shortness of breath, inc. chest pain
Information has been received from a school nurse concerning a senior in high school who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). the school nurse reported a case of break through chickenpox that began on approximately 07-MAR-2005. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
About 1 month after vaccination developed fever to 101 degrees for 1 week. This was followed by "black out spells". Within several days a facial tic started along with her head jerking toward the left. After medical work up, the diagnosis was "movement disorder". Takes NEURONTIN 600mg tid for symptoms.  3/30/09 MR received for DOS 12/22-26/2008 with D/C DX:  Spells.  Paresthesias.  Other Dx:  Lyme Arthritis.  Asthma.  Pt presented with 10 day hx of L sided twitching. Pt reports loss of time and orientation but not full LOC. Feels like "spacing out". PE (+) for L sided head twitching x1. Admitted for video EEG. 5/18/09 PCP records received from 12/4/08-4/16/09 which include neuro consults. First presented with c/o confusion and loss of time which have been worsening over recent months. Sent for EEG and labs. TC from parent on 12/19/08 reporting onset of tics-involuntary movements of the head to the left x several days. Seen 12/22/08 where arm jerks were also reported. Sent for video EEG. started on gabepentin with improvement in head jerking, sleep and neck pain.  Still having episodes where pt spaces out. Assessment:  Head twitches suggestive of tics. Follow-up received 03/11/2010. She has no improvement in her facial and head tics. In October 2009, she was having difficulty sleeping at night due to the tics, and as a result was falling asleep in her classes. She has been followed by the college health services. Dr increased patient's dosage of NEURONTIN to 900 mg in the am, 600 mg at noon, and 900 mg in the evening. She also takes trazadone in the evening and that has been helping her sleep. Patient's mother was asked if Dr has determined any cause for the tics, the mother states the etiology is unknown, but that patient's Lyme disease in 2004 may have contributed to the problem as well. The Lyme disease went undiagnosed for a while before she was treated. The mother is not necessarily blaming the vaccines, but wonders if they may have been a contributing factor due to the past history of Lyme disease. Patient's mother also reports that patient has had increased asthma symptoms since moving to another city. She does not necessary feel that it is due to the vaccines, but the facial and head tics have been significant in changing her quality of life, and the asthma symptoms are now limiting her even more in her activities. Follow-up: 6/4/10 Call received from pt's mother. Pt has had increased head twitching, and has now been diagnosed with vocal chord dysfunction which causes spasms of the vocal chord and aggravates her asthma, and potentially could block her airway. She has been referred to Neurology and has an appt on August 5th, 2010. In additional she is seeing a neuro/psych physician in July at clinic. Pt still attends college. Her mother states the neurological problem is affecting her cognition and attention span. She was a 3.9 grade average student at High School and now she struggles to maintain a 2.6 in college. She is also seeing Dr. who is an allergist.
I have a 2.5 inch raised area on my LT deltoid. It is hot to touch. It is erythematous from shoulder joint down to my elbow and spreads around my upper arm. There is some puritis.
Pt c/o her throat was closing on her.  Pt states she couldn't breath and her chest was heavy.  Pt did not want Epi pen for a long time, she wanted just to go home.  Pt  looked dishelved so her friend came and said pt's voice is not normal.  It took awhile for us  to convince pt to take the Epi pen and to go the ambulance.  Pt finally agreed after awhile. She felt much better after th epi pen. Pt was wheeled out on the stretcher by the paramedic. Given 0.3mg EpiPen. Taken to ED.
Nausea, vomiting, fever, sore muscles (7/17-7/21) Hives on injection site with burning and itching feeling (7/24)
A non-serious spontaneous report of inadvertently administered expired FLUMIST was received from a health professional concerning an eight-year-old female. Neither the patient's past medical history nor any concomitant medications were reported. The product expired on 15-Dec-2010. The patient received the expired FLUMIST on 21-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
CROOKED WALK; FEET SWOLLEN AND CRAMPED; FEET ARE  HOT; LOSS OF APPETITE/CANT EAT  ANYTHING; SEVERE DIARRHEA; HIVES ALL OVER BODY AND ALL OVER FACE; FEET HURT; This spontaneous report received from a patient concerned a female of unspecified age of unknown race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry: Unknown) dose was not reported, 1 total administered on 30-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient had crooked walk and the patient's feet ware hot, swollen, and hurt. Patient had loss of  appetite and cant eat anything. Patient broke out in hives all over body and all over face. Patient experienced severe diarrhea. The patient had been hospitalized three times and given only Maalox and opioids. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the crooked walk, severe diarrhea, loss of appetite/cant eat anything, feet swollen and cramped, hives all over body and all over face, feet hurt and feet are hot was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210532364-COVID-19 VACCINE AD26.COV2.S-crooked walk, feet swollen and cramped, feet are hot, loss of appetite/cant eat anything, severe diarrhea. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210532364-COVID-19 VACCINE AD26.COV2.S-hives all over body and all over face, feet hurt. This event(s) is labeled per RSI and is therefore considered potentially related.
Burning in arches of feet, heart palpitations, feeling buzzy, loss of feeling in toes and fingers, hives
fever; nausea; headache; feeling unwell; This is a spontaneous report from a contactable consumer (patient reported for herself). A 66-year-old Elderly non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number and Expiration date: not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 05Mar2021 at 14:45 (at the age of 66-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included diabetes mellitus, neuropathy, obesity, arthritis. No covid prior vaccination. The patient had allergies to sulfa drugs. Concomitant medication(s) included Cholestyramine; Metformin; Atorvastatin and Losartan potassium, all taken for an unspecified indication, start and stop date were not reported. The patient previously took ampicillin and experienced drug hypersensitivity. No other vaccine in four weeks. No covid tested post vaccination. On 07Mar2021, the patient experienced fever, nausea, headache and feeling unwell. No treatment was received to treat the events. The patient outcome of the events was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.